Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1718-2020Class II

Endocuff Vision: models ARV 110, 120, 130, 140

Boddingtons Plastics, Ltd. / initiated 2020-03-11 / Terminated / root cause: labeling and UDI

Boddingtons Plastics Ltd began a recall of Endocuff Vision: models ARV 110, 120, 130, 140 Intended Use: ENDOCUFF VISION is a device attached to the distal end of a colonoscope, designed to maintain and... on . FDA classified it as Class II and gives the reason as "Updated Instructions For Use- to contraindications and potential complications/adverse events of the colonoscopy procedure (without using Endocuff Vision Device)". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1718-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Boddingtons Plastics, Ltd.
Product
Endocuff Vision: models ARV 110, 120, 130, 140 Intended Use: ENDOCUFF VISION is a device attached to the distal end of a colonoscope, designed to maintain and maximize the viewable mucosa during endocosopic therapy by manipulating colonic folds
Product code
FED Endoscopic Access Overtube, Gastroenterology-Urology
Reason for recall
Updated Instructions For Use- to contraindications and potential complications/adverse events of the colonoscopy procedure (without using Endocuff Vision Device)
Root cause tag
labeling and UDI
FDA root cause
Other
Action
Boddingtons issued Medical Device Correction Notice dated 3/13/20 to the Distributor stating reason for correction and take the following actions: It is not necessary to return any Endocuff Vision you have in stock, as this recall affects the IFU and not the device. It can continue to be used, provided users are aware of the updated information in the IFU. Healthcare letters dated 3/2/620 was distributed There is no requirement to replace existing stock. New stock with the updated IFU will become available in May 2020. Ensure relevant staff members are informed of this recall, including locums, biomedical engineers, operating theatre staff and relevant clinicians who may decide to monitor for adverse events, as applicable. If you have supplied or transferred any potentially affected product to another facility or organisation, let that facility know of the recall immediately by providing a copy of this letter. Please complete the attached acknowledgement form immediately even if you do not have any affected stock and return it to [email protected] or fax to 004401622833701 to enable Boddingtons to reconcile this process.
Quantity in commerce
13202 Units US
Distribution
Nationwide Foreign:
Product codes and lots
All batches distributed prior to 1st May 2020.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1718-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1718-2020Class IITerminatedVoluntary: Firm initiated